GIANT BIOGENE (02367) issued a total of 7.684 million shares on January 21 due to the exercise of stock options.

21/01/2025

GMT Eight

GIANT BIOGENE (02367) announced on January 21, 2025 that a total of 7.684 million shares were issued due to the exercise of the stock purchase option plan.

Shenzhen King Brother Electronics Technology (301041.SZ) shareholder Wu Shouyong has cumulatively reduced holdings by 1.146 million shares.

Northbound funds | Northbound trading saw a net buying of 1.535 billion yuan, with domestic funds continuing to scramble for Semiconductor Manufacturing International Corporation (00981) while selling China National Offshore Oil Corporation (00883).

Contact: contact@gmteight.com

GIANT BIOGENE (02367) issued a total of 7.684 million shares on January 21 due to the exercise of stock options.

RECOMMEND

The FDA has approved Johnson & Johnson's Spravato (esketamine) nasal spray for the treatment of adults with treatment-resistant depression (TRD).

GMTEight List of A-share restricted sales and lifting restrictions | January 22nd

Content is king! Netflix (NFLX.US) has once again won the "streaming game".